Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study

European Journal of Surgical Oncology

Volumn 36, Issue 6, 2010, Pages 589-593

  Pomel, C ^a   Ferron, G ^b   Lorimier, G ^c   Rey, A ^d   Lhomme, C ^d   Classe, J M ^e   Bereder, J M ^f   Quenet, F ^g   Meeus, P ^h   Marchal, F ⁱ   Morice, P ^d   Elias, D ^d  

^a CENTRE JEAN PERRIN   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c CENTRE PAUL PAPIN   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE RENÉ GAUDUCHEAU   (France)

^f UNIVERSITY HOSPITAL OF NICE   (France)

^g CENTRE VAL D AURELLE   (France)

^h CENTRE LÉON BÉRARD   (France)

ⁱ CENTRE ALEXIS VAUTRIN   (France)

Author keywords

HIPEC; Ovarian epithelial carcinomatosis

Indexed keywords

GLUCOSE; OXALIPLATIN;

ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; HUMAN; HYPERTHERMIA; LAPAROTOMY; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEMPERATURE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HEMORRHAGE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953120029     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.04.005     Document Type: Article

References (20)

1. Copeland L.J., and Gershenson D.M. Ovarian recurrences in patients with no macroscopic tumor at second look laparotomy. Obstet Gynecol 68 6 (1986) 873-874
2. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
3. Alberts D.S., Liu P.Y., Hannigan E.V., et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus inrtavenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335 26 (1996) 1950-1955
4. Markman M., Bundy B.N., Alberts D.S., et al. Phase III trial of standard dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the gynaecologic oncology group, southwestern oncology group, and eastern cooperative oncology group. J Clin Oncol 19 4 (2001) 1001-1007
5. Armstrong D.K., Bundy B., Wenzel L., et al., Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354 (2006) 34-43
6. Markman M. Consolidation/maintenance chemotherapy for ovarian cancer. Curr Oncol Rep 5 6 (2003 Nov) 454-458 [Review]
7. Piccart M.J., Floquet A., Scarfone G., et al. Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy. Int J Gynecol Cancer 13 Suppl. 2 (2003) 196-203
8. Esquivel J., Sticca R., Sugarbaker P., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surgical Oncol 14 1 (2007) 128-133
9. Helm C.W., Bristow R.E., Kusamura S., Baratti D., and Deraco M. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 98 (2008) 283-290
10. Dindo D., Demartines N., and Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 2 (2004 Aug) 205-213
11. Sugarbaker P.H. Peritonectomy procedures. Surg Oncol Clin N Am 12 3 (2003 Jul) 703-727
12. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
13. Fu S., Kavanagh J.J., Hu W., and Bast Jr. R.C. Clinical application of oxaliplatin in epithelial ovarian cancer. Int J Gynecol Cancer 16 5 (2006 Sep-Oct) 1717-1732
14. Sugarbaker P.H., Cuniffe W., Belliveau J.F., de Bruin E., and Graves T. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1 (1988) 66-79
15. Elias D., Honoré C., Ciuchendéa R., et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 95 9 (2008 Sep) 1164-1171
16. Marcotte E., Sideris L., Drolet P., et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis. Ann Surg Oncol 15 10 (2008 Oct) 2701-2708 [Epub 2008 Jul 25]
17. Ceelen W.P., Peeters M., Houtmeyers P., Breusegem C., De Somer F., and Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol 15 2 (2008 Feb) 535-541
18. Fagotti A., Paris I., Grimolizzi F., et al. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. Gynecol Oncol 113 3 (2009 Jun) 335-340
19. Gori J., Castaño R., Toziano M., et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 15 2 (2005 Mar-Apr) 233-239
20. Kim J.H., Lee J.M., Ryu K.S., et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer. J Surg Oncol 101 2 (2010 Feb 1) 149-155